Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23163332 | 0.77 | KMT2A (0.64) | ALDH1A1KMT2A | |
| SCHEMBL6683011 | 0.77 | KMT2A (0.64) | ALDH1A1KMT2A | |
| SCHEMBL1305942 | 0.75 | — | — | |
| SCHEMBL704379 | 0.75 | ALDH1A1 (0.59) | ALDH1A1KMT2A | |
| SCHEMBL6131066 | 0.73 | — | — | |
| SCHEMBL6907916 | 0.73 | — | — | |
| SCHEMBL6924137 | 0.71 | KMT2A (0.64) | ALDH1A1KMT2A | |
| SCHEMBL3492594 | 0.69 | KMT2A (0.36) | ALDH1A1KMT2A | |
| SCHEMBL158028 | 0.68 | KMT2A (0.60) | ALDH1A1KMT2A | |
| SCHEMBL1305503 | 0.67 | NR1I2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107847606-A | Conjugates comprising self-degrading groups and methods relating thereto | 乐高化学生物科学股份有限公司 | 2018-03-27 | — | — | CN | disclosed |
| EP-2908634-A1 | PRENYLATED CHALCONE FORMULATION FOR THE TREATMENT OF BEES | Bioactive-tech Sp. z z.o. (PL) | 2015-08-26 | — | — | EP | disclosed |
| US-9045524-B2 | Selective caspase inhibitors and uses thereof | NOVAGENESIS FOUNDATION (CH) | 2015-06-02 | — | — | US | disclosed |
| WO-2014060803-A1 | PRENYLATED CHALCONE FORMULATION FOR THE TREATMENT OF BEES | BIOACTIVE-TECH SP. Z O.O. (PL) | 2014-04-24 | — | — | WO | disclosed |
| US-8563599-B2 | Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2013-10-22 | — | — | US | disclosed |
| US-8450560-B2 | Gene cluster of prenyl transferase from Hevea brasiliensis | BRIDGESTONE CORPORATION (JP) | 2013-05-28 | — | — | US | disclosed |
| US-20120157394-A1 | SELECTIVE CASPASE INHIBITORS AND USES THEREOF | NEW WORLD LABORATORIES, INC. (CA) | 2012-06-21 | — | — | US | disclosed |
| US-20110144195-A1 | METHODS FOR SYNTHESIZING GLYCINOLS, GLYCEOLLINS I AND II, COMPOSITIONS OF SELECTED INTERMEDIATES, AND THERAPEUTIC USES THEREOF | XAVIER UNIVERSITY OF LOUISIANA | 2011-06-16 | — | — | US | disclosed |
| US-20100186111-A1 | GENE CLUSTER OF PRENYL TRANSFERASE FROM HEVEA BRASILIENSIS | BRIDGESTONE CORPORATION (JP) | 2010-07-22 | — | — | US | disclosed |
| US-7692066-B2 | Gene cluster of prenyl transferase from Hevea brasiliensis | BRIDGESTONE CORPORATION (JP) | 2010-04-06 | — | — | US | disclosed |
| WO-2008003774-A1 | METHOD FOR PRODUCING ENANTIOPURE FLAVANONES | Technische Universität Dresden (DE) | 2008-01-10 | — | — | WO | disclosed |
| US-20070067866-A1 | Gene cluster of prenyl transferase from Hevea brasiliensis | BRIDGESTONE CORPORATION | 2007-03-22 | — | — | US | disclosed |
| EP-0381205-A2 | Process for the polymerisation of polar compounds | WACKER-CHEMIE GMBH (DE) | 1990-08-08 | — | — | EP | disclosed |
| US-4087468-A | MAGNESIUM WITH ZINC, CADMIUM, MERCURY OR INDIUM HALIDE, AN ALIPHATIC HALIDE PROMOTER AND AN ETHER DILUENT | PHILLIPS PETROLEUM COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144195-A1 | METHODS FOR SYNTHESIZING GLYCINOLS, GLYCEOLLINS I AND II, COMPOSITIONS OF SELECTED INTERMEDIATES, AND THERAPEUTIC USES THEREOF | GPER1, ESR2, GNE | ALDH1A1 3569/4885KMT2A 3625/4885 |
| US-20120157394-A1 | SELECTIVE CASPASE INHIBITORS AND USES THEREOF | CASP1, VIP, CASP5 | ALDH1A1 4093/4885KMT2A 3517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.